Professor Weiss said he had been "barely involved" in negotiating with companies regarding funding. DHSS negotiated on his behalf. Read more about Professor Weiss said he had been "barely involved" in negotiating with companies regarding funding. DHSS negotiated on his behalf.
The Blood Products Laboratory did not have expertise in propagating retroviruses and Professor Weiss believed they would need to seek collaboration to produce a mass-use anti-HTLV-3 RIA. Read more about The Blood Products Laboratory did not have expertise in propagating retroviruses and Professor Weiss believed they would need to seek collaboration to produce a mass-use anti-HTLV-3 RIA.
In his evidence, Dr Brian McClelland explained that he approached Wellcome because they were the only UK-based manufacturer and he was not optimistic about getting a positive response from US suppliers. Read more about In his evidence, Dr Brian McClelland explained that he approached Wellcome because they were the only UK-based manufacturer and he was not optimistic about getting a positive response from US suppliers.
There was an agreement in a Scottish National Blood Transfusion Service directors meeting "to test all donors once an antibody test was available." Read more about There was an agreement in a Scottish National Blood Transfusion Service directors meeting "to test all donors once an antibody test was available."
The Blood Products Laboratory had been discounted as serious contenders for the task of an RIA test. Read more about The Blood Products Laboratory had been discounted as serious contenders for the task of an RIA test.
The regional transfusion directors described the meeting of the Advisory Committee on the National Blood Transfusion Service Working Group on AIDS as "unproductive", there was "no new leaflet, no finance and no positive move towards full donor screening." Read more about The regional transfusion directors described the meeting of the Advisory Committee on the National Blood Transfusion Service Working Group on AIDS as "unproductive", there was "no new leaflet, no finance and no positive move towards full donor screening."
Dr Brian McClelland stated in regards to his overview of screening tests: "I can get no clear picture of when or how a serviceable assay will be provided." Read more about Dr Brian McClelland stated in regards to his overview of screening tests: "I can get no clear picture of when or how a serviceable assay will be provided."
Dr Tedder and Dr Weiss repeatedly emphasised their concern about antibody positive samples as potentially infective. Read more about Dr Tedder and Dr Weiss repeatedly emphasised their concern about antibody positive samples as potentially infective.
The Scottish National Blood Transfusion Service were preparing to pursue their own evaluation unilaterally in the absence of a uniform UK approach. Read more about The Scottish National Blood Transfusion Service were preparing to pursue their own evaluation unilaterally in the absence of a uniform UK approach.
Dr Cash wrote to Dr Bell to express his dismay at the Department of Health and Social Security and the National Blood Transfusion Service regarding HIV screening. Read more about Dr Cash wrote to Dr Bell to express his dismay at the Department of Health and Social Security and the National Blood Transfusion Service regarding HIV screening.